Furthermore, a positron emission tomography (PET)/CT scan using 18F-FDG was conducted on three mice showing reduction in tracer uptake in RT-CT, and in Pep R treated tumors, consistent with reduced tumor metabolism as previously reported for CXCR4 antagonists [21] (Figure S2). The gene discussed is CXCR4; the disease is neoplasm.